Across TCGA patient cohorts, CLECL1 mutation is significantly associated with the RNA expression of many other genes, with 32 significant associations in total. UCEC shows the largest number of these associations.

The most reproducible CLECL1-associated genes across cancer lineages are MTND5P18, RPL36P1, and MIR1263. Each is linked with CLECL1 in more than 1 cancer types. Because this analysis shows association rather than direction, both CLECL1-to-partner and partner-to-CLECL1 results are reported.

Each partner links to its own Q-omics profile.

mutation associated genes by consensus

Ranked by combined sampling and lineage consensus. X-score (CLECL1→partner) and Y-score (partner→CLECL1) are standardized regression coefficients; both directions are reported because the association is undirected. p-values are from the association test.

Lineage	Partner gene	X-score	Y-score	p(X)	p(Y)	Sampling consensus	Lineage consensus
SKCM	MTND5P18 →	+0.018	+4.495	<.001	.007	3	2
LUSC	RPL36P1 →	+0.124	+5.321	.002	.002	3	2
COAD	MIR1263 →	+1.494	+7.741	<.001	.009	3	1
COAD	MIR1283-1 →	+0.726	+7.741	<.001	.009	3	1
COAD	MIR1179 →	+1.171	+7.741	<.001	.009	3	1
COAD	MTATP6P30 →	+0.147	+7.741	<.001	.009	3	1

Each partner links to its Q-omics profile. Showing the 6 strongest of 32 associations by consensus.

Exploration

CLECL1 survival (RNA) · tumor vs normal (RNA) · all CLECL1 data types